Livagen (20 mg Vial) Dosage Protocol

Quickstart Highlights

Livagen (Lys-Glu-Asp-Ala) is a synthetic tetrapeptide bioregulator studied for its effects on peptidase inhibition and epigenetic modulation in aging tissues^[1]^[4]. Preclinical research demonstrates Livagen strongly inhibits enkephalin-degrading enzymes^[1] and induces heterochromatin decondensation with gene reactivation in aged cells^[4]. No standardized human dosing exists; this educational protocol presents a once-daily subcutaneous approach based on analogy with similar peptide bioregulators.

Reconstitute: Add 3.0 mL bacteriostatic water → ~6.67 mg/mL concentration.

Typical daily range: 0.5–2.0 mg once daily (gradual titration over 8–12 weeks).

Easy measuring: At 6.67 mg/mL, 1 unit = 0.01 mL ≈ 0.0667 mg (66.7 mcg) on a U-100 insulin syringe.

Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Standard / Gradual Approach (3 mL = ~6.67 mg/mL)

Week	Daily Dose (mg)	Units (per injection) (mL)
Weeks 1–2	0.5 mg (500 mcg)	7.5 units (0.075 mL)
Weeks 3–4	1.0 mg (1000 mcg)	15 units (0.15 mL)
Weeks 5–6	1.5 mg (1500 mcg)	22.5 units (0.225 mL)
Weeks 7–12	2.0 mg (2000 mcg)	30 units (0.30 mL)

Frequency: Inject once daily subcutaneously. This schedule uses a 3.0 mL dilution to yield measurable volumes on standard insulin syringes. For ≤10-unit (≤0.10 mL) administrations (e.g., the initial 7.5-unit dose), consider 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

Draw 3.0 mL bacteriostatic water with a sterile syringe.

Inject slowly down the vial wall; avoid foaming.

Gently swirl/roll until dissolved (do not shake).

Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

Plan based on an 8–16 week daily protocol with gradual titration.

Peptide Vials (Livagen, 20 mg each):

8 weeks ≈ 4 vials
12 weeks ≈ 7 vials
16 weeks ≈ 10 vials

Insulin Syringes (U-100):

Per week: 7 syringes (1/day)
8 weeks: 56 syringes
12 weeks: 84 syringes
16 weeks: 112 syringes

Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.

8 weeks (4 vials): 12 mL → 2 × 10 mL bottles
12 weeks (7 vials): 21 mL → 3 × 10 mL bottles
16 weeks (10 vials): 30 mL → 3 × 10 mL bottles

Alcohol Swabs: One for the vial stopper + one for the injection site each day.

Per week: 14 swabs (2/day)
8 weeks: 112 swabs → recommend 2 × 100-count boxes
12 weeks: 168 swabs → recommend 2 × 100-count boxes
16 weeks: 224 swabs → recommend 3 × 100-count boxes

View Supplier

Protocol Overview

Concise summary of the once-daily regimen.

Goal: Support cellular homeostasis and regenerative processes in aging tissues^[3].

Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).

Dose Range: 0.5–2.0 mg daily with gradual titration.

Reconstitution: 3.0 mL per 20 mg vial (~6.67 mg/mL) for accurate unit measurements.

Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Research Disclaimer